Cambridge Investment Research Advisors Inc. Increases Holdings in 23andMe Holding Co. (NASDAQ:ME)

Cambridge Investment Research Advisors Inc. raised its holdings in shares of 23andMe Holding Co. (NASDAQ:ME – Get Rating) by 3.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 214,010 shares of the company’s stock after acquiring an additional 7,213 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in 23andMe were worth $462,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in 23andMe by 259.1% in the first quarter. Vanguard Group Inc. now owns 17,551,125 shares of the company’s stock valued at $67,221,000 after purchasing an additional 12,663,268 shares during the last quarter. Alphabet Inc. purchased a new stake in 23andMe in the third quarter valued at approximately $19,267,000. BlackRock Inc. increased its position in 23andMe by 41.0% during the third quarter. BlackRock Inc. now owns 16,102,036 shares of the company’s stock worth $46,053,000 after purchasing an additional 4,683,691 shares during the last quarter. State Street Corp raised its stake in 23andMe by 201.0% during the second quarter. State Street Corp now owns 3,567,075 shares of the company’s stock worth $8,846,000 after purchasing an additional 2,382,040 shares during the period. Finally, Renaissance Technologies LLC acquired a new position in shares of 23andMe in the 1st quarter valued at $7,692,000. Hedge funds and other institutional investors own 29.49% of the company’s stock.

23andMe Trading Down 2.4 %

Shares of ME opened at $2.04 on Friday. 23andMe Holding Co. has a twelve month low of $1.74 and a twelve month high of $6.31. The firm has a market capitalization of $932.79 million, a P/E ratio of -2.87 and a beta of 1.37. The stock’s fifty day simple moving average is $2.12 and its 200 day simple moving average is $2.44.

About 23andMe

(Get Rating)

23andMe Holding Co operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit.